Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 1,036,029 |
|
|||||
| News | - | ||||||
| Day High | 0.1509 | Low High |
|||||
| Day Low | 0.1413 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Biolase Inc | BIOL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0043 | -2.87% | 0.1456 | 18:57:42 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.1493 | 0.1413 | 0.1509 | 0.145 | 0.1499 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,685 | 1,036,029 | US$ 0.1466971 | US$ 151,982 | - | 0.1251 - 9.88 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:56:08 | formt | 3,000 | US$ 0.1456 | USD |
Biolase Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 321.55k | 2.30M | - | 49.16M | -37.62M | -16.38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Biolase News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/03/2024 | 16:17 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
| 5/17/2024 | 05:42 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/13/2024 | 15:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/13/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/06/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/08/2024 | 05:31 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 3/05/2024 | 05:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/27/2024 | 15:14 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/23/2024 | 15:05 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 2/21/2024 | 15:39 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 2/21/2024 | 06:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/15/2024 | 16:15 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIOL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.18 | 0.1829 | 0.1413 | 0.1620438 | 2,392,572 | -0.0344 | -19.11% |
| 1 Month | 0.17 | 0.20 | 0.1413 | 0.1697755 | 3,053,792 | -0.0244 | -14.35% |
| 3 Months | 0.135 | 0.257 | 0.1255 | 0.1720597 | 5,008,025 | 0.0106 | 7.85% |
| 6 Months | 1.19 | 1.33 | 0.1251 | 0.1758382 | 3,376,581 | -1.04 | -87.76% |
| 1 Year | 7.60 | 9.88 | 0.1251 | 3.74 | 3,258,863 | -7.45 | -98.08% |
| 3 Years | 73.30 | 594.00 | 0.1251 | 27.94 | 2,283,457 | -73.15 | -99.80% |
| 5 Years | 130.00 | 594.00 | 0.1251 | 62.83 | 4,152,663 | -129.85 | -99.89% |
Biolase Description
| Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States. |
